With an extensive 19-year background in Information Technology, Guan Hwang Ho boasts a wealth of experience spanning Pharmaceutical, Automotive, Solar (Photovoltaic), Semiconductor, and Electronics (DRAM) manufacturing. He has demonstrated proficiency in both global and regional (APAC) operational support, contributing significantly to successful project rollouts.

Guan Hwang Ho has been instrumental in the implementation, rollout, and operations of over 10 IT Manufacturing Applications, managing projects in greenfield and brownfield settings across international landscapes, including the United States, Switzerland, Germany, Portugal, China, Singapore, India, and Malaysia.

Passionate about the realm of Digital Manufacturing, Guan Hwang Ho is driven to apply his skills and knowledge to harness technology for enhancing innovation and efficiency within manufacturing processes.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit http://www.roche.com.